FDA approves BioMarin's phenylketonuria drug

FDA approved Palynziq pegvaliase-pqpz from BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) to treat phenylketonuria (PKU) in

Read the full 149 word article

User Sign In